EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incorporating familial risk, lifestyle factors, and pharmacogenomic insights into personalized noncommunicable disease (NCD) reports for healthcare funder beneficiaries participating in the Open Genome Project

Manie De Klerk, Nicole Van Der Merwe, Johny Erasmus, Lindiwe Whati, Kelebogile E Moremi, Daniel W Olivier, Maritha J Kotze iD

Annals of Human Genetics · 2025

DOI: 10.1111/ahg.12582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Human Genetics, 2025. Verfasst von Manie De Klerk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Health Care Leadership, University of Stellenbosch Business School, Cape Town, South Africa. Hauptthemen laut MEDLINE: Precision Medicine, Noncommunicable Diseases, Life Style, Genetic Testing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council, Department of Science and Innovation and the Technology Innovation Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

An ethics‐guided decision‐making framework was developed for applying pathology‐supported genetic testing, a multifaceted pharmacodiagnostic approach that translates population risk stratification into clinical utility. We introduce this service, supported by the Open Genome Project, which aligns with the beneficence principle in personalized medicine.

Methods

Genetic testing of six noncommunicable disease pathways was conducted as part of a pilot program, benchmarked against a readiness checklist for implementation of genomic medicine in Africa. Patient referral criteria were determined using healthcare funder claims data, employing the Adjusted Clinical Groupers and Resource Utilization Band risk rating structure to identify potential nonresponders to treatment.

Results

Three of the 135 doctors (2.2%) invited expressed immediate disinterest in the pilot, while 24 (17.8%) actively participated. Inherited, lifestyle‐triggered, and therapy‐related pathologies were simultaneously assessed in case reports, with special medical scheme reimbursement tariff codes applied to 25 patient referrals. The findings were used by the participating genetic counselor to select three patients for whole exome sequencing, utilizing a novel, level‐up data processing algorithm for adaptive reporting.

Conclusion

This study demonstrated the implementation of genomics into an evolving workflow for patients with a history of frequent clinic visits. Eliminating the cost barrier provided valuable insights to guide future reimbursement policy decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineNoncommunicable DiseasesLife StyleGenetic TestingPharmacogeneticsHumansFemaleMaleRisk Factors

Stichwörter der Autor:innen

benefit‐sharinggeneral practicegenetic counselinggenomic medicinelearningmedical schemeopen innovationpathology‐supported genetic testing

Autor:innen und Institutionen

  • Health Care Leadership, University of Stellenbosch Business School, Cape Town, South Africa.
  • Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • FamGen Counselling, Bloemfontein, South Africa.
  • Momentum Group, Cape Town, South Africa.
  • Gknowmix (Pty) Ltd., Cape Town, South Africa.
  • Division of Chemical Pathology, Department of Pathology, National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa.

ORCID-Profile: Maritha J Kotze

Förderung

  • South African Medical Research Council
  • Department of Science and Innovation and the Technology Innovation Agency

Zitieren

APA

De Klerk, M., Van Der Merwe, N., Erasmus, J., Whati, L., Moremi, K. E., Olivier, D. W., & Kotze, M. J. (2025). Incorporating familial risk, lifestyle factors, and pharmacogenomic insights into personalized noncommunicable disease (NCD) reports for healthcare funder beneficiaries participating in the Open Genome Project. Annals of Human Genetics. https://doi.org/10.1111/ahg.12582

Vancouver

De Klerk M, Van Der Merwe N, Erasmus J, Whati L, Moremi KE, Olivier DW, et al. Incorporating familial risk, lifestyle factors, and pharmacogenomic insights into personalized noncommunicable disease (NCD) reports for healthcare funder beneficiaries participating in the Open Genome Project. Annals of Human Genetics. 2025. doi:10.1111/ahg.12582

BibTeX
@article{DeKlerk2025,
  author = {De Klerk, Manie and Van Der Merwe, Nicole and Erasmus, Johny and Whati, Lindiwe and Moremi, Kelebogile E and Olivier, Daniel W and Kotze, Maritha J},
  title = {Incorporating familial risk, lifestyle factors, and pharmacogenomic insights into personalized noncommunicable disease (NCD) reports for healthcare funder beneficiaries participating in the Open Genome Project},
  journal = {Annals of Human Genetics},
  year = {2025},
  doi = {10.1111/ahg.12582}
}
Kostenlos starten →